Titan Pharmaceuticals Inc (NASDAQ:TTNP)

1.05
Delayed Data
As of 1:22pm ET
 +0.05 / +5.00%
Today’s Change
0.95
Today|||52-Week Range
3.95
-20.75%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues35.0K40.0K77.0K40.0K
 
 
 
 
 
Depreciation And Amortization98.0K101.0K102.0K105.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses3.2M3.4M3.6M4.0M
 
 
 
 
 
Research And Development2.1M2.1M2.5M2.7M
 
 
 
 
 
Total Operating Expenses3.3M3.5M3.7M4.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.3M-3.4M-3.6M-4.1M
 
 
 
 
 
Extraordinary Credit936.0K422.0K190.0K2.0K
 
 
 
 
 
Other Expenses-46.0K10.0K-20.0K-123.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.3M-3.0M-3.5M-4.2M
 
 
 
 
 
Net Income-2.3M-3.0M-3.5M-4.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS21.2M21.2M21.2M21.2M
 
 
 
 
 
Shares To Calculate EPS Diluted21.6M21.4M21.2M21.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.15-$0.16-$0.17-$0.20
 
 
 
 
 
EPS Diluted-$0.15-$0.16-$0.17-$0.20